Crowdonomics
All companies
LARADA SCIENCES INC logo

LARADA SCIENCES INC

Operating

Healthcare · Murray, UT

Estimated pre-money ⓘ
$43.4M
As of Jun 2017 · from Reg CF Offering (2017) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$2,629,349
Crowd $0 · Private $2.6M · 4 rounds since 2008
Latest share price
$5.75
Reg CF Offering (2017) offering price

Financials

FY2015–FY2016 · from SEC filings · hover any figure for its source
$3.9M
−$329K
2015
$7.4M
−$2.1M
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2015 reviewed*
FY2016 reviewed*
Income statement
Revenue
$3,866,171
$7,449,487
Cost of goods sold
$718,997
$890,488
Gross margin
81%
88%
Net income
-$329,064
-$2,117,909
Taxes paid
$210
$1,010
Balance sheet
Cash
$507,735
$220,022
Accounts receivable
$476,827
$1,404,864
Total assets
$1,634,234
$3,591,585
Short-term debt
$331,709
$1,535,780
Long-term debt
$670,188
$2,076,708
Total liabilities
$1,001,897
$3,612,488
Other
Headcount
—
30

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$43.4M
est. pre-money
Reg CF · Common · Jun 2017

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2016
Preferred Stock · 60.3%Common stock · 39.7%
ClassOutstandingVotes / shareShare of totalLast price
Preferred Stockpreferred4,558,757—60.3%—
Common stock2,996,229—39.7%—
Total7,554,986100%

Principal holders% as the filing states it, Jun 22, 2017

  • 37Ventures LLC1,927,114 Preferred Stock26.6%of votes
  • Everyone else (not named in filings)73.4%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Common Stock · Jun 2017Withdrawnvia StartEngine
Raised $0 / $1MEst. pre-money $43.4M
Raised $400KInvestors 2
Raised $400.5KInvestors 16
Raised $1.8MInvestors 31

Team

8 people
Claire Roberts
Chief Executive Officer
Adam Ward
Chief Operating Officer
Kelly Brodbeck
Chief Strategy Officer
Perry Christensen
Chief Financial Officer
Scott Wilson
President
Terri Simpson
Chief Marketing and Sales Officer
Jennifer Jackenthal
VP of Strategic Clinic Operations
Dr. Krista Lauer
Medical Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

31 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-WSep 26, 20170001665160-17-000420
    EDGAR
  • Form C/AJun 26, 20170001665160-17-000228
    EDGAR
  • Form CJun 22, 20170001665160-17-000225
    EDGAR
  • Form DMar 27, 20140001396156-14-000002
    EDGAR
  • Form DAug 11, 20110001396156-11-000001
    EDGAR
  • Form D/ANov 2, 20100001396156-10-000002
    EDGAR
  • Form D/ANov 1, 20100001396156-10-000001
    EDGAR
  • Form DAug 10, 20090001396156-09-000004
    EDGAR
Source: SEC EDGARCIK 0001396156DEShare price $5.75Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.